Xylo Technologies

growth-positive

Xylo Technologies announced that Viewbix, in which it holds an indirect stake, has received approval for its shares to be listed on the Nasdaq Capital Market. Viewbix shares are expected to begin trading under the symbol VBIX around June 5, 2025. Additionally, Xylo Technologies is set to be acquired by L.I.A Pure Capital, as approved by its shareholders. The company is also advancing in the EV charging sector with a new wireless system installation and has secured its first institutional client for the PORTO EV. These developments indicate a positive growth trajectory for Xylo Technologies.

growth-positive

Xylo Technologies Ltd., a technology company based in Israel, announced that Viewbix Inc., in which Xylo holds an indirect stake through its ownership in Gix Internet Ltd., has received approval for its shares to be listed on the Nasdaq Capital Market. This uplisting is seen as a significant milestone for Viewbix, which operates in the digital advertising space through its subsidiaries. Xylos strategic investment in Gix Internet supports Viewbixs growth and visibility in the capital markets. The event is expected to positively impact Xylo by enhancing its investment portfolio and partnerships.

growth-positive

Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has successfully installed a wireless charging system for electric vehicles in collaboration with a leading supplier of robotic parking facilities. This system, which integrates advanced machine learning and AI algorithms, addresses the challenges of EV charging in robotic facilities by enabling seamless and efficient charging. The solution is designed to optimize energy utilization and enhance user convenience, marking a significant step towards revolutionizing EV charging in automated parking environments. This development is expected to support the growing demand for space-efficient parking systems and sustainable urban living.

growth-positive

Xylo Technologies Ltd., through its affiliate Revoltz Ltd., has secured its first institutional client for the PORTO EV, marking a significant step in its commercial expansion strategy. The institutional customer, a prominent logistics company, will integrate PORTO EVs into its urban delivery fleet, highlighting the growing demand for sustainable electric mobility solutions. This order follows Revoltzs successful launch of its commercial phase in Israel, which included a $2.7 million agreement for the delivery of 50 PORTO EV units to a local distributor. Xylo, traded on Nasdaq, focuses on innovative growth partnerships in medical solutions, digital commerce, and electric vehicles.

growth-positive

Xylo Technologies Ltd. has announced the first global commercial rollout of the PORTO EV, an electric micro vehicle designed for last-mile delivery, through its affiliate Revoltz Ltd. The rollout follows regulatory approval by the Israeli Standards Institute and marks the transition from development to deployment. Revoltz has delivered the first 50 units to its exclusive distributor in Israel as part of a five-year, $2.7 million distribution agreement, which includes an initial commitment of 150 vehicles in the first year. The distributor will manage sales, service, and maintenance, targeting local delivery fleets and small businesses. This move is seen as a significant step in meeting the rising demand for sustainable urban mobility solutions.

growth-positive

Xylo Technologies Ltd., a technology company based in Israel, has announced that Revoltz Ltd., a company in which it holds a significant stake, has won the TAIPEI CYCLE d&i award 2025 in the Micro-Mobility category. This award is a prestigious international recognition for innovation and design in the bicycle and micro-mobility sector. Revoltzs product was showcased at the Taipei Cycle Show, a major B2B event in the cycling industry, emphasizing innovation and sustainability. Xylo Technologies, traded on Nasdaq, focuses on advanced medical solutions, digital commerce, and electric vehicle markets, with partnerships including Charging Robotics, Inc. and Revoltz Ltd.

growth-positive

Xylo Technologies Ltd., through its subsidiary Revoltz Ltd., has received approval from the Israeli Standards Institute to sell and market the PORTO EV micro vehicle in Israel. This approval is a significant milestone, allowing riders as young as 16 to operate the vehicle without a drivers license, thus lowering barriers to adoption. The PORTO EV is designed for last-mile delivery, offering robust design and functionality. Israels demand for eco-friendly transportation solutions makes it an ideal market for the PORTO EV. In 2023, Revoltz entered an exclusive $2.7 million distribution agreement with a premier distributor in Israel, which includes purchasing 150 vehicles in the first year. This development supports Charging Robotics goal of expanding its presence in the EV market.

growth-negative

Xylo Technologies reported a significant decrease in revenue, down 64% from the first half of 2023, with a net loss of $8.17 million. Despite an improvement in loss per share, the companys shares have dropped by 15% over the past week. Looking forward, Xylo Technologies is expected to see a 34% annual growth in revenue over the next two years, outperforming the US Medical Equipment industrys forecasted growth of 8.1%. However, the article highlights potential risks, including four warning signs for the company. The analysis provided is based on historical data and forecasts, and does not constitute financial advice.

growth-positive

Xylo Technologies Ltd., through its affiliate ParaZero Technologies Ltd., has announced a new partnership with a leading Tier 1 defense OEM company to integrate its advanced drone safety systems for military and medical missions. ParaZero will initially provide 50 systems for testing, with plans for a larger pilot program upon successful validation. This collaboration aims to enhance medical field mission deliveries, particularly in remote areas, and underscores ParaZeros commitment to entering defense markets and improving healthcare logistics. The adapted systems are expected to enter commercial production by the end of 2024.

growth-positive

Xylo Technologies Ltd., a technology company based in Israel, has announced the development of a new three-wheel electric cargo bike through its affiliate Revoltz Ltd. The bike is designed for the European and UK markets, offering enhanced stability, increased payload capacity, and advanced safety features. It aims to address urban transportation challenges and promote sustainable transportation. The bike combines manual and assisted pedaling, making it suitable for urban delivery services. The first prototype is expected within three months, with commercialization anticipated in early 2025. Xylos portfolio includes partnerships in advanced medical solutions, digital commerce, and electric vehicles.

growth-neutral

Xylo Technologies Ltd., a technology company based in Tel Aviv, announced a reverse split of its American Depositary Receipt (ADR) program. Effective August 5, 2024, the ratio will change from 15 ordinary shares per ADS to 40 ordinary shares per ADS. This change will not affect the companys ordinary shares or share capital. The Bank of New York Mellon, as the depositary bank, will handle the exchange of ADSs. The reverse split aims to adjust the ADS structure without altering ownership percentages, except for minor adjustments due to fractional ADSs. Xylo is involved in advanced medical solutions, digital commerce, and electric vehicle markets.

growth-positive

Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has received its first commercial order for a wireless charging system designed for automatic parking facilities. The order, placed by Parking Design Ltd., involves an initial batch of 12 systems and marks a significant step forward in the evolution of automated parking and EV charging technologies. Charging Robotics system uses machine learning and AI to optimize EV charging, addressing the growing demand for electricity. The collaboration with Parking Design is expected to enhance the efficiency and convenience of EV charging in automated parking environments, with systems scheduled to be operational by 2025.

growth-positive

Xylo Technologies Ltd., through its subsidiary Charging Robotics Inc., has received its first commercial order for a wireless charging system designed for automatic parking facilities. The order, placed by Parking Design Ltd., marks a significant step in the evolution of automated parking and EV charging technologies. The system, which uses AI and machine learning algorithms, optimizes EV charging based on various parameters. This collaboration is expected to enhance the efficiency and convenience of automatic parking facilities. The order is scheduled for fulfillment throughout 2025, with the systems being integrated into Parking Designs facilities.

growth-positive

Xylo Technologies Ltd., a technology-based company, announced that its affiliate, Gix Internet Ltd., has signed a non-binding memorandum of understanding (MOU) with a robotics company specializing in AI autonomous robotics solutions. The MOU outlines a share exchange transaction, which, upon completion, will make the Robotics Company a wholly owned subsidiary of Gix. This transaction is expected to provide Gix with opportunities for growth and technological advancements in AI and robotics. The shareholders of the Robotics Company will exchange their shares for 30% of Gixs shares, with options to increase their holdings upon achieving certain milestones. Xylo, traded on Nasdaq, focuses on innovative growth partnerships in medical solutions, digital commerce, and electric vehicles.

growth-positive

Xylo Technologies Ltd., a technology company listed on Nasdaq, announced the successful development of Bubbl, an advanced writing tool by Metagramm Software Ltd., which is 19.99% owned by Xylo. Bubbl utilizes AI, Machine Learning, NLP, and Deep Learning to offer personalized and customized text writing, distinguishing itself from common AI writing tools. It supports multiple writing modes and caters to various profiles such as Business, Medical, Academic, and Blogging. The first version is set to launch for selected users in Q3 2024. Xylo is involved in various sectors, including medical solutions, digital commerce, and electric vehicles, with several affiliated companies.

growth-positive

Xylo Technologies Ltd., a technology-based company, has announced a letter of intent for the strategic acquisition of a leading German company specializing in AI predictive maintenance and condition monitoring technologies. This acquisition aligns with Xylos strategy to expand its portfolio in advanced AI technologies across various industries. The German company has been a leader in AI and machine learning for over a decade, providing services to sectors like aerospace, aviation, and transportation. Xylo will initially acquire 51% of the company for 1.5 million Euros, with the remaining shares to be acquired based on 2024 EBITDA results. This move is supported by Xylos newly appointed senior advisor, who brings extensive expertise in AI.

growth-positive

Xylo Technologies Ltd., through its subsidiary Charging Robotics, Inc., has reached the final stages of developing a software for EV charging management in collaboration with Make My Day Ltd. The software, which uses AI and machine learning algorithms, aims to optimize electricity usage in automatic car parks by prioritizing EV charging based on various parameters. This development addresses the growing concern of electricity shortages for EV charging due to increased EV adoption. Charging Robotics has installed its wireless charging system in a pilot project in Tel Aviv, Israel. The collaboration with Make My Day is expected to add value for future customers by enabling efficient use of limited electricity supply.

Neutral

Xylo Technologies Ltd., previously known as Medigus Ltd., has filed its 2023 Annual Report on Form 20-F with the Securities and Exchange Commission. The report includes audited financial statements for the year ended December 31, 2023. Xylo is a technology-based company based in Israel, focusing on innovative growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets. The companys affiliations include Polyrizon Ltd., Gix Internet Ltd., Jeffs’ Brands, Eventer Technologies Ltd., Fuel Doctor, Inc., Charging Robotics, Ltd., Revoltz Ltd., Parazero Technologies Ltd., and Zig Miami 54 LLC.

growth-positive

Medigus Ltd, a technology-based company engaged in advanced innovative technologies, announced a corporate rebranding to reflect its current focus in innovation technologies. The company will change its name to Xylo Technologies Ltd and its Nasdaq trading symbol will change to XYLO. The rebranding includes a new name, an update to the company’s corporate logo, and a new website. The company will begin trading on the Nasdaq Capital Market under its new name and new trading symbol upon the opening of the market on April 18, 2024.

growth-positive

Medigus Ltd., a technology-based company, has announced a significant achievement by its subsidiary, Charging Robotics Ltd., which has successfully installed its wireless charging system for an automated parking system (APS). This is reportedly the first installation of a wireless charging system for automatic car parks. The installation was in an automatic car park facility in Tel Aviv, Israel. The wireless charging system is intended to solve a problem for electric vehicles (EVs) parked in automatic car parks, which are in constant movement and thus prevent the use of charging cables.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (EV) and charging solutions, announced that its EV joint venture, Revoltz Ltd, completed its first production batch of 50 units of its micro-mobility electric vehicle, ‘PORTO’. The completion of production is a significant step in enabling Revoltz to prepare for shipment of units in accordance with the Agreement signed over the past year. During 2023, Revoltz and a premier distributor in Israel entered into the Agreement, worth $2.7 million in revenue, with the goal to steer the advanced PORTO EVs into Israel and adjacent territories.

growth-positive

Medigus Ltd, a technology-based company, announced that its subsidiary, Charging Robotics Ltd, has successfully installed its wireless charging system for an automated parking system (APS) in Tel Aviv, Israel. This is the first installation of a wireless charging system for automatic car parks. The system is designed to solve the problem of charging electric vehicles (EVs) in automatic car parks, where the constant movement of vehicles prevents the use of charging cables. The system was developed in cooperation with Make My Day Ltd.

growth-positive

Medigus Ltd, a technology company, announced that ParaZero Technologies Ltd, an aerospace company focused on drone safety systems and 18.68% owned by Medigus, has expanded its collaboration with Vayu Aerospace Corporation, a US-based drone original equipment manufacturer. ParaZero will customize its SafeAir system to be integrated at the design stage of Vayu’s G-1MKII VTOL aircraft. The two companies also have performance-based regulatory compliance testing and validation planned for the near future. The global market for VTOL unmanned aerial vehicles is projected to reach a size of $27.5 Billion by 2030.

growth-positive

Medigus Ltd., a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, has announced the launch of pre-orders for the PORTO, an innovative electric vehicle (EV) from its subsidiary, Revoltz Ltd. The PORTO is designed for urban delivery solutions, combining long-range capability, robust design, and exceptional agility. This marks a significant step in Revoltzs commitment to offer sustainable, efficient and cutting-edge solutions for urban logistics.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced that its subsidiary, Charging Robotics Ltd, has completed a significant milestone towards the installation of its wireless charging system in automatic car parks. This is part of its pilot program with an automatic car park provider in Israel. The successful experiment involved transferring high voltage electricity in a wireless manner for electric vehicle charging. The next step is the full charging of an EV using the developed wireless charging system.

growth-positive

Medigus Ltd. has initiated a wireless EV charging pilot through its subsidiary, Charging Robotics Ltd. The project, which began in August 2023, is supported by funding from the Israel Innovation Authority. The wireless charging systems are designed for automated parking setups, addressing the lack of charging infrastructure in such environments. The funding, totaling approximately $445,000, is expected to drive substantial growth within the expanding Automated Parking System market, projected to reach $5.2 billion by 2032.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, has announced the launch of a unique pilot of a wireless charging solution for electric vehicles (EVs) in automated parking systems. The project is led by Charging Robotics Ltd., a subsidiary of Fuel Doctor Holdings, Inc., which is owned by Medigus. The project received funding from the Israel Innovation Authority, with a total approved budget of approximately USD 445,000. The wireless charging system is designed to meet the growing demand for EV charging in automated parking systems.

growth-positive

Medigus Ltd, a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies, announced the successful completion of its safety solution development for a Fortune 500 leading global automotive manufacturer’s proprietary drone program. The project was carried out by ParaZero Technologies Ltd, an aerospace company focused on drone safety systems for commercial drones and urban air mobility aircraft, which is 33.36% owned by Medigus. The successful completion of this project reinforces ParaZero’s reputation as a provider of advanced safety solutions across various aerial platforms.

growth-positive

Medigus Ltd, a technology company, announced that Jeffs Brands Ltd, a company in which it owns a 34.87% stake, has signed a non-binding letter of intent with Sky Growth Partners Ltd to invest in advanced laser-based wireless charging technology systems for drones and unmanned aircrafts. The investment will be used to establish a new Israeli company that will develop, manufacture and market the technology. Jeffs Brands will hold a 70% equity interest in the new company after an investment of $2.5 million.

growth-positive

Medigus Ltd, a technology company, announced that Jeffs Brands Ltd, a data-driven E-commerce company owned 34.87% by Medigus, has entered into a non-binding letter of intent with Sky Growth Partners Ltd to invest in a Digital Light Processing (DLP) laser-based system for drone countermeasure solutions. The investment will be used to establish a new Israeli company that will develop, manufacture and market the technology. Jeffs Brands will invest $2 million and hold a 70% equity interest in the new company. The system will be used for defense and commercial applications.

growth-positive

Medigus Ltd, a technology company, announced that its subsidiary, Charging Robotics Ltd, has received approval for funding from the Israeli Innovation Authority for a pilot project. The project involves installing and demonstrating wireless charging solutions for electric vehicles in automated parking systems. The system will be tested in an automated parking system installed by Parkomot. The total approved budget for this project is approximately NIS 1.2 million ($445,000), of which the Israel Innovation Authority will finance 50%.

growth-positive

Medigus Ltd, a technology company, announced that its subsidiary, Metagramm Software Ltd, is developing Bubbl, a state-of-the-art writing tool utilizing Machine Learning, Natural Language Processing (NLP), Artificial Intelligence (AI) and Deep Learning technologies. The Global Writing Enhancement Software market is expected to reach $887.9 million by 2030, and the company anticipates Bubbl to significantly impact this market. Bubbl offers a unique, user-friendly tool that enables users to enhance and re-write their text effortlessly, catering to a variety of writing needs with different profiles and features.

growth-positive

Medigus Ltd., a technology company engaged in innovative internet technologies, electric vehicle and charging solutions, and advanced medical solutions, has announced its financial results for the first half of 2023. The companys revenues reached $53.3 million, a 52% increase compared to the same period in 2022. Medigus subsidiary, Charging Robotics, merged with a US public company and commenced trading on the OTC Market. The company also sold its entire stake in Odysight.ai Inc. for approximately $5.7 million in cash. Additionally, ParaZero, a drone safety company, commenced trading on Nasdaq following a $7.8 million IPO.

growth-positive

Medigus Ltd, a technology company, has announced its plans to establish a presence in Miami by acquiring, improving, renovating, developing, and selling commercial properties. The company has signed an operating agreement with a US-based partner for the formation of a joint venture that will purchase, renovate, manage, and sell a commercial property in Miami. The initial capital contribution paid by Medigus is $2 million and its initial percentage interest in the JV is 60%, while the Partner interest is 40%. Medigus intends to continue and explore additional opportunities in Miami for the purpose of acquiring, improving, renovating, further developing and selling the properties.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, has converted a $1,240 thousand convertible loan into shares of AI Systems Ltd. Following the conversion, Medigus will hold a 36% stake in AI Systems and become its largest shareholder. AI Systems, a technology company traded on the Tel Aviv Stock Exchange, is in negotiations to merge new activity and further expand its technological endeavors.

growth-positive

Medigus Ltd announced that its subsidiary, ParaZero Technologies, has expanded into the Latin American drone market through a development agreement with Black Square, an industrial drone producer. Black Square will integrate ParaZeros patented parachute technology into its drone platforms to enhance safety. The collaboration solidifies ParaZeros commitment to promoting safety in the commercial drone and urban air mobility ecosystem in the region. ParaZeros SafeAir system offers a holistic safety approach for drone operations, ensuring a safe descent in the event of an emergency. The partnership with Black Square allows ParaZero to further its presence and deepen its ties in Latin America.

growth-positive

Medigus Ltd announced that its subsidiary Gix Internets 76% owned company Viewbix reported $48 million in revenue for the first half of 2023, representing an 18.5% increase in revenues compared to the second quarter of 2022. The increase in revenues was driven by Viewbixs digital content platform and search platform. Operating income for the first half of 2023 decreased compared to the previous year due to increased expenses related to a reorganization transaction and higher traffic-acquisition costs. EBITDA for the first half of 2023 also decreased compared to the previous year. Net cash from operating activities increased for the first half of 2023. Medigus is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.

growth-positive

Medigus Ltd announced the official release of the SafeAir M350 Pro, a parachute system designed for DJIs newest enterprise drone. The system is developed by ParaZero Technologies, an aerospace company focused on drone safety systems. Equipped with integrated sensors, the SafeAir system autonomously mitigates flight risks by cutting power to the drone, deploying a parachute, and bringing the drone to the ground safely. The system has received regulatory approvals for advanced operations and is available for purchase on ParaZeros website and through authorized distributors worldwide. Medigus Ltd is a technology company engaged in electric vehicle charging solutions, advanced medical solutions, and innovative internet technologies.

growth-positive

Medigus Ltd, a technology company, announced that its aerospace company ParaZero Technologies Ltd has received a second order for its custom drone safety system from a major automotive manufacturer. The automotive manufacturer plans to integrate ParaZero’s SafeAir drone safety system into their proprietary aircraft from the design stage. This follows an agreement previously signed with the automotive manufacturer for the development of a bespoke safety solution for its proprietary drone program.

growth-positive

Medigus Ltd, a technology company engaged in electric vehicle charging solutions, announced that its subsidiary, Charging Robotics Ltd., received a Letter of Intent from an automatic car park provider in Israel to evaluate its wireless charging system for electric vehicles. The system is designed to meet the unmet need of charging electric vehicles in automatic car parks, which are gaining popularity due to their efficiency and cost-effectiveness. The wireless charging system offers seamless integration, a convenient charging experience, and scalability and adaptability.

growth-negative

Medigus Ltd has sold its entire stake in ScoutCam Inc. to existing shareholders and office holders, primarily to Mr. Mori Arkin, for approximately $6 million in cash. ScoutCam is a leading provider of Predictive Maintenance and Condition Based Monitoring solutions. The sale of the stake is a growth-negative impact on Medigus.

growth-positive

Medigus Ltd announced that Viewbix Inc, owned by Medigus subsidiary Gix Internet, reported consistent growth in revenues for the first quarter of 2023. Viewbixs digital content platform showed strong improvement in EBITDA. Revenues reached $20.9 million, with $15,752 thousand coming from the digital content platform. The operating loss for the quarter was $76 thousand. EBITDA amounted to $658 thousand. The companys net cash from operating activities was positive at $12 thousand. Medigus Ltd is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.

growth-negative

Medigus reported its full year 2022 financial results, with revenue of US$91.9m and a net loss of US$9.82m. The companys shares are up 5.0% from a week ago. The article also mentions 2 warning signs for Medigus that investors should be aware of. It concludes with an invitation to join a paid user research session.

growth-positive

Medigus Ltd, a technology company specializing in advanced medical solutions, internet technologies and electric vehicle charging solutions, announced that ScoutCam Inc, a company in which Medigus owns a 27% stake, has received an order from a leading US-based orthopedic healthcare corporation. The order is for ScoutCams video technologies and products to be integrated into a minimally invasive surgical device. The revenues from this partnership are expected to amount to $2.5 million in 2023, with potential for further growth in subsequent years.

growth-positive

Medigus Ltd, a technology company, announced that its affiliate Gix Media Ltd has acquired an additional 10% of Cortex Media Group Ltd, increasing its holdings to 80%. The purchase was completed at a valuation of Cortex of approximately $27 million, for a consideration of $2.7 million in cash. This follows Gix Medias initial purchase of 70% of Cortexs share capital in October 2021. The increase in Cortexs current valuation is primarily due to an increase in its results and activity and its improved financials.

growth-positive

Medigus Ltd announced that its subsidiary, Eventer Technologies, will merge with AI Conversation Systems, a company listed on the Tel-Aviv Stock Exchange. Eventer shareholders will hold 74.99% of the merged company. The merger will allow Eventer to become a public company and continue to grow in the conferences and events industry. The transaction is subject to closing conditions and Eventer must be valued at a minimum of $5.7 million. Eventer has developed an event management system that helps customers increase sales volume and reduce marketing resources. Medigus is a technology company focused on advanced medical solutions, digital commerce, and electric vehicle markets.

Growth-Positive

Medigus Ltd, a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced a $1.6 million cash capital distribution. The company will distribute cash capital of $0.85 per American Depositary Share (ADS) to ADS holders and holders of Nasdaq listed warrants, as of the record date of December 20, 2022. The payment is expected on or about December 28, 2022. The cash capital distribution is not subject to tax withholding in Israel.

growth-positive

Medigus Ltd, through its subsidiary Charging Robotics Ltd, is set to release a beta version of a user interface application for its wireless charging robot. The app is being developed in collaboration with Make My Day, a company specializing in EV fleet management. The app will allow customers to order the charging service offered by the robots, receive billing information, driving instructions, and real-time data about EV electricity consumption and battery state of charge. The first product to be released by Charging Robotics will be a robot designed to automatically charge electric vehicles for disabled drivers. The system is expected to start pilot tests in Q1 2023. The Make My Day app will serve as the user interface for Charging Robotics, providing driving navigation algorithms and real-time communication with vehicles.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions, announced that the Tel Aviv District Court Economic Department has approved the companys motion for a cash capital distribution of up to $1.6 million. The companys board of directors has resolved to make a cash capital distribution of $1.6 million to the holders of the companys ADSs and eligible warrant holders. The distribution will be made in proportion to their respective holdings. The exact timing and details of the cash distribution will be announced separately. Medigus is focused on growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets.

growth-positive

Medigus Ltd, a technology company, has announced that its subsidiary, Charging Robotics Ltd, has signed a non-binding letter of intent for a planned securities exchange agreement with Fuel Doctor, Inc. The agreement, if signed, will result in Charging Robotics becoming a wholly owned subsidiary of Fuel Doctor, with Medigus receiving 80% of Fuel Doctors share capital. Charging Robotics is developing an automatic wireless charging system for public parking lots, which aims to lower EV charging infrastructure installation costs. Medigus is focused on growth partnerships in advanced medical solutions, digital commerce, and electric vehicle markets. The transaction is subject to customary closing conditions.

growth-positive

Medigus Ltd. has announced an expansion of its healthcare activities through an investment agreement with Clearmind Medicine Inc., a psychedelic pharmaceutical biotech company. Medigus will invest $1.25 million in exchange for approximately 2 million units of Clearmind, representing 5.02% of the company. Clearmind focuses on the discovery and development of psychedelic-derived therapeutics for mental health and other health problems. The two companies also plan to form a joint venture in the food industry based on Clearminds intellectual property. Medigus will be issued shares and warrants as part of the agreement. The investment amount will be paid in cash and through the issuance of Medigus American Depository Shares. Medigus will also be entitled to 10% of the initial equity of a potential venture in the psychedelics area. The agreement aims to capitalize on the growing market for psychedelic drugs.

growth-positive

Medigus has entered into an agreement to acquire IP and know-how, including a provisional patent, for a wireless robotic charging pad for electric vehicles. The company plans to invest in the initial development of the technology and consolidate its electric vehicle and wireless charging activities under a new subsidiary. The acquisition is expected to have a positive impact on the companys growth.

growth-positive

Medigus Ltd has announced the acquisition of controlling interest in Smart Repair Pro, Inc. and Purex, Corp, two data-driven e-commerce companies operating on the Amazon Marketplace. Medigus now owns approximately 50.01% of the issued and outstanding share capital of each company. Smart Repair Pro and Purex achieved over 214% growth in revenues in 2020 compared to 2019, with approximately $2.2 million in revenues in 2020. Smart Repair Pro also plans to launch a new brand and product line on the Amazon Marketplace and pursue a Business-to-Consumer (B2C) business model with a direct sales channel. Medigus is a technology company engaged in advanced medical solutions and innovative internet technologies.

growth-positive

Medigus Ltd has announced the signing of a share purchase agreement and revolving loan agreement with Eventer Technologies Ltd. Medigus will invest up to $1,000,000 in Eventer and loan up to an additional amount of $1,250,000. Upon closing, Medigus will hold 50.1% of Eventers share capital. Eventer is a company engaged in providing interactive automated online & offline enterprise ticketing and events platform. Medigus believes that it has invested in an effort to further promote Eventers penetration and expansion into target markets, primarily in North America. Eventers clients include leading production companies, Israeli Electric Corporation, American Express, Live Nation, and more.

growth-positive

Medigus Ltd, a technology company engaged in advanced medical solutions and innovative internet technologies, has announced its entry into e-commerce business by signing a definitive agreement to acquire a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., two data-driven e-commerce companies, operating on the Amazon Marketplace. Medigus will hold 50.01% of the issued and outstanding share capital of each of the companies, acquired through a combination of a cash investment in the companies, and an acquisition of additional shares from the companies’ current shareholders in consideration for restricted ADSs of Medigus and a cash component.

growth-positive

Medigus Ltd announced that its subsidiary, ScoutCam Ltd, accepted a quote of $2.4 million for its single-use miniature video cameras from a Fortune 500 multinational healthcare corporation. The two companies will work together to develop a complete visualization solution for a minimally invasive surgical end-user product. The partnership is expected to generate tens of millions of dollars in revenue per year. ScoutCam is a leading provider of customized visual solutions, while Medigus is a technology company developing minimally invasive tools and direct visualization technology.

growth-negative

Medical device company Medigus announced that its CEO, Chris Rowland, will step down effective February 28, 2019. Rowland will continue to work with the company as a consultant. An executive committee will take over Rowlands responsibilities until a replacement is appointed. Medigus specializes in developing minimally invasive endosurgical tools and innovative imaging solutions. The companys flagship product is the MUSE system, used for the treatment of GERD. Medigus is traded on the Nasdaq Capital Market and the TASE. The CEOs resignation is a growth-negative impact on the company.

growth-positive

Medigus Ltd. is in advanced negotiations with multinational companies to license its MUSE reflux treatment technology worldwide. The company expects to receive upfront payments worth millions of dollars. The MUSE system is an FDA and CE approved endoscopic device for the treatment of GERD.

growth-positive

Medigus Ltd. has announced that NASA has incorporated its micro ScoutCam™ 8.0 HD camera into its Visual Inspection Poseable Invertebrate Robot 2 (VIPIR2). The camera will be used as part of NASAs Robotic Refueling Mission 3 (RRM3), which aims to test tools and technologies for refueling and repairing satellites in orbit. This collaboration is the result of an official tender bid with the United States government. Medigus is honored to support NASA on RRM3 and believes its innovative technology will greatly contribute to the mission. The micro ScoutCam™ 8.0 HD is custom designed for NASA and features a miniature size, remarkable image quality, customizable optics, waterproof materials, and adaptability in extreme temperatures.

growth-positive

Medigus Ltd. has signed an exclusive distribution agreement with Micro-Tech Endoscopy USA for its Medigus Ultrasonic Surgical Endostapler (MUSE) system in the US for the treatment of heartburn. The agreement is for an initial term of three years with annual increases in minimum purchases for the first seven years. Medigus also has an exclusive distribution agreement with Micro-Tech Europe for the MUSE system in Germany.

growth-positive

Medigus Ltd. has raised $10 million in an underwritten public offering. The company develops minimally invasive endosurgical tools and direct visualization technology, including the FDA-cleared MUSE system for the treatment of gastroesophageal reflux disease. The offering consisted of 2,837,674 units at a price of $3.50 per unit. Each unit includes one American Depositary Share (ADS) and one Series C warrant to purchase one ADS. The Series C warrants began trading on the Nasdaq. Medigus is a Nasdaq and Tel Aviv-listed medical device company based in Omer, Israel.

growth-positive

Medigus Ltd. has entered into a development agreement with A.M. Surgical, Inc. to develop and manufacture an integrated visualization device based on its micro ScoutCam technology. The agreement requires Medigus to provide prototypes and production of the device, with a total project budget of $780,000. The device has the potential to offer a higher level of surgical control and visualization during endoscopic carpal tunnel release procedures. Medigus CEO Chris Rowland expressed satisfaction with the partnership, while A.M. Surgical CEO Ather Mirza highlighted Medigus research and development proficiency. The agreement is expected to contribute to the growth of Medigus Ltd.

growth-positive

Medigus Ltd., a medical device company, announced that new data from its clinical research on the MUSE system will be presented at Digestive Disease Week. The MUSE system is a minimally invasive endosurgical tool used for the treatment of gastroesophageal reflux disease (GERD). The data highlights the safety and efficacy of the MUSE system, which offers an incision-less procedure for GERD patients. The company remains dedicated to building on its clinical success. The poster presentations will take place on June 2-5, 2018 in Washington, DC.

growth-positive

Medigus Ltd. has announced a distribution agreement with MELEKIRMAK in Turkey, Azerbaijan, and Georgia. The agreement requires MELEKIRMAK to purchase a minimum of approximately EUR 1 million of Medigus Ultrasonic Surgical Endostapler (MUSE) equipment over five years. The MUSE system is a single-use flexible transoral stapler used to treat GERD. Medigus aims to provide a more cost-effective and minimally invasive option for GERD treatment. The company is focused on gaining MUSE adoption in key markets worldwide.

growth-positive

Medigus Ltd., a medical device company, announced the completion of the first MUSE procedure in Spain. The procedure was successful and the patient was released from the hospital. The MUSE system is a single-use flexible transoral stapler used to treat gastroesophageal reflux disease (GERD). The device requires no incisions, resulting in greater patient comfort and reduced hospital stays. Medigus aims to expand availability of the MUSE procedure in other areas of Europe in the future. The company specializes in developing minimally invasive endosurgical tools and imaging solutions.

growth-positive

Medigus Ltd. has announced a five-year distribution agreement for its MUSE System in Germany with Micro-Tech Europe. Under the agreement, Micro-Tech Europe will be the exclusive distributor for the MUSE System in Germany. The MUSE System is a medical device used for incisionless transoral fundoplication, a procedure to treat GERD. Medigus is pleased to have Micro-Tech Europe as a partner and believes the agreement will help expand market access and drive sales of the MUSE System. Micro-Tech Europe shares Medigus commitment to innovation and high-quality products. The distribution agreement is a growth-positive development for Medigus.

growth-negative

Medigus Ltd., a medical devices company, raised $7.5 million on Nasdaq for its non-surgical treatment for GERD. However, the companys market cap is currently half the amount it raised. Medigus is facing difficulty in penetrating the market with its MUSE system, resulting in low revenue. The company is now focusing on Europe and China for distribution and conducting clinical trials for CFDA certification in China. Medigus liquidity problems have led to cutbacks in operations. The recent fundraising will keep the company operational for at least another year. The companys share price has dropped significantly since the offering.

growth-negative

Medigus has begun substantial layoffs of sales personnel in the US and employees at its Israel development center. The company is currently re-launching its product after the initial launch was deemed unready for the market. They are making progress in attaining reimbursement from medical insurance companies for patients using the device. However, the company needs a large amount of money to survive and will likely have to raise capital and seek strategic partnerships. Medigus principal shareholders include OrbiMed Advisors LLC, Senvest Management, Armistice Capital, and Migdal Insurance and Financial Holdings Ltd.

growth-positive

Medigus, a medical-device company based in Israel, has developed the MUSE (Medigus Ultrasonic Surgical Endostapler) System, an incision-free outpatient procedure to treat acid reflux. The procedure reconstructs the esophageal valve through the mouth, eliminating the need for surgery. The company has received FDA and CE approvals and has already been used in over 200 procedures in top-tier US facilities. Medigus has also signed a $17 million distribution deal in China and is looking to expand to Spain. The company is considering applying its technology to other gastrointestinal-tract procedures and is expecting strategic interest from other companies. Medigus sees 2016 as a pivotal year for its growth and aims to become a global organization while keeping its headquarters in Israel.

growth-positive

Medical devices company Medigus Ltd. has filed a prospectus with the US Securities and Exchange Commission for listing its shares as American depository receipts. After the process is completed, the companys security will be listed on Nasdaq, allowing it to conduct financing rounds in the US. Medigus had NIS 2.6 million revenue in 2014, and its loss grew to NIS 22.6 million. The companys CEO stated that they are working towards getting their product accepted in the market as an alternative to conventional surgery. The American Medical Association has recommended that government insurance companies should include Mediguss procedure in their health baskets.

growth-positive

Medigus, an Israeli company developing minimally invasive surgical tools, has been awarded a Japanese patent for its miniature camera, the micro ScoutCam. The patent, titled Small Diameter Video Camera Heads and Visualization Probes and Medical Devices Containing Them, became effective in December 2014 and will be valid until September 2030. Medigus has also applied for approval of this patent in the U.S., Europe, South Korea, and Israel.

growth-positive

Medical device maker Medigus closed a $5.6 million funding round with 5 backers. The companys MUSE clinical results were published in the journal Surgical Endoscopy, showing positive 6-month results in treating patients with gastroesophageal reflux disease. Medigus has also received FDA clearance for its next-gen MUSE technology and raised $11 million in a private placement round.

growth-positive

NASA has adopted Israeli company Medigus technology for a robot to inspect equipment in deep space. Medigus tiny camera, called the micro ScoutCam 1.2, will provide vision capabilities to the robot, allowing technicians on Earth to get a close-up look at equipment. The camera is the smallest in the world, with a 224 x 224 pixel resolution. The robot, called VIPIR, will be used on the International Space Station to test remote-repair technologies developed by NASA and the Canadian Space Agency.

growth-positive

Medigus, an Israel-based device maker, has successfully closed an $11.1 million private placement funding round. The funding was split evenly between Israeli and overseas investors and will be used for general corporate activities. The company plans to expand the use of its MUSE system and enhance its position in the minimally invasive endosurgical market. Medigus expects to generate revenue this year from its FDA-cleared MUSE system for treating acid reflux. The company has previously received FDA clearance for its next-gen MUSE technology. Medigus has been experiencing growth, with previous funding rounds worth a total of $15 million.

growth-positive

Medigus Ltd. has received FDA clearance for its next generation MUSE system, a minimally invasive tool for treating GERD. The system aims to reduce or eliminate GERD symptoms in patients, who are at higher risk of developing esophageal cancer. The clearance is a significant milestone for Medigus and positions the company for sustained, significant long-term growth. The new MUSE system is easier to use and has improved features, such as an improved graphical user interface and enhanced digital resolution. The surgical endoscope remains disposable for patient safety.

Growth-Positive

Israel-based medical device company, Medigus, has raised $7 million in a funding round through the sale of shares and options. The funding round saw participation from investors in the U.S. and Israel. The funds will be used to expedite Medigus’ penetration into the U.S and Europe markets and to support the enrollment of new patients into new and existing medical centers. Earlier this year, Medigus closed an $8 million private placement in support of its SRS Endoscopic system, a treatment for gastroesophageal reflux disease, which won FDA clearance for the U.S. market in May 2012.

growth-positive

Medigus Ltd. has appointed Christopher Rowland as CEO, replacing founder and current CEO Dr. Elazar Sonnenschein. Dr. Sonnenschein will become global COO and assist in the transition. The appointment is subject to approval by the companys shareholders. Medigus aims to become a market leader in minimally invasive medical markets and establish its SRS system as an alternative to more invasive surgical procedures. The company is at the forefront of the transition from invasive gastric surgery procedures to advanced minimally invasive treatment techniques. The SRS system allows treatment of chronic reflux through a one-time endoscopic procedure. The appointment of Chris Rowland is expected to support the companys growth and expansion globally.